Whole Biome's mission is to be the trusted brand in bringing the public improved health solutions through microbiome interventions.
We are developing microbiome interventions using our proprietary discovery platform.
Whole Biome integrates cutting edge laboratory science and computational analysis to gain a comprehensive and high resolution view of each individual's microbiome. We then apply machine learning algorithms to identify broader trends in biochemical and metabolic pathways across populations. These high resolution data and analytic tools enable us to identify specific microbiome markers and novel interventions.
Whole Biome is developing medical foods, which are synbiotic formulations, comprised of novel, naturally-occurring strains, that increase butyrate production in the gut microbiome. These formulations are being evaluated for the treatment of metabolic syndrome and other diseases.
We are currently testing these beta products with our clinical partners and applying our discovery platform to identify which patients benefit from these synbiotics and to optimize the formulations to maximize impact.
If you are interested in our product for patients with IBS, please visit our beta website here: